Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INGAP Peptide in insulin deficient patients
NCT00034255Phase 2Completed
- Sponsor
- GMP Endotherapeutics
- Start
- Dec 2001
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of INGAP peptide in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by GMP Endotherapeutics. Started Dec 2001; status: completed.
02
Drugs
INGAP peptide
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00034255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034255.